Christopher J. Nardo's Insider Trades & SAST Disclosures
Christopher J. Nardo's most recent trade in Dermata Therapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher J. Nardo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dermata Therapeutics Inc | Christopher J. Nardo | Senior VP, CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | J. Christopher Nardo | Senior VP, CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy | |
| Dermata Therapeutics Inc | Christopher J. Nardo | Senior VP, CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Christopher J. Nardo | Senior VP, CDO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Christopher J. Nardo | Senior VP, Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Dermata Therapeutics Inc | Christopher J. Nardo | Senior VP, Development | 17 Aug 2021 | 50,000 | 0 | - | - | Series 1 Preferred Stock | ||
| Dermata Therapeutics Inc | Christopher J. Nardo | Senior VP, Development | 17 Aug 2021 | 2,439 | 2,439 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges